106 related articles for article (PubMed ID: 8289454)
1. The effect of sulindac on colon polyps: circumvention of a transformed phenotype--a hypothesis.
Waddell WR
J Surg Oncol; 1994 Jan; 55(1):52-5. PubMed ID: 8289454
[TBL] [Abstract][Full Text] [Related]
2. Adenomatous polyposis coli, protein kinases, protein tyrosine phosphatase: the effect of sulindac.
Waddell WR; Miesfeld RL
J Surg Oncol; 1995 Apr; 58(4):252-6. PubMed ID: 7723369
[TBL] [Abstract][Full Text] [Related]
3. Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP).
Ulusan AM; Rajendran P; Dashwood WM; Yavuz OF; Kapoor S; Gustafson TA; Savage MI; Brown PH; Sei S; Mohammed A; Vilar E; Dashwood RH
Cancer Prev Res (Phila); 2021 Mar; 14(3):325-336. PubMed ID: 33277315
[TBL] [Abstract][Full Text] [Related]
4. Sulindac for polyposis of the colon.
Waddell WR; Ganser GF; Cerise EJ; Loughry RW
Am J Surg; 1989 Jan; 157(1):175-9. PubMed ID: 2535920
[TBL] [Abstract][Full Text] [Related]
5. Relationship between APC genotype, polyp distribution, and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis.
Guldenschuh I; Hurlimann R; Muller A; Ammann R; Mullhaupt B; Dobbie Z; Zala GF; Flury R; Seelentag W; Roth J; Meyenberger C; Fried M; Hoppeler T; Spigelman AD; Scott RJ
Dis Colon Rectum; 2001 Aug; 44(8):1090-7; discussion 1097-9. PubMed ID: 11535846
[TBL] [Abstract][Full Text] [Related]
6. Rectal cancer after sulindac therapy for a sporadic adenomatous colonic polyp.
Matsuhashi N; Nakajima A; Shinohara K; Oka T; Yazaki Y
Am J Gastroenterol; 1998 Nov; 93(11):2261-6. PubMed ID: 9820411
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term sulindac therapy on colonic polyposis.
Rigau J; Piqué JM; Rubio E; Planas R; Tarrech JM; Bordas JM
Ann Intern Med; 1991 Dec; 115(12):952-4. PubMed ID: 1659272
[No Abstract] [Full Text] [Related]
8. Tissue prostaglandin levels in familial adenomatous polyposis patients treated with sulindac.
Nugent KP; Spigelman AD; Phillips RK
Dis Colon Rectum; 1996 Jun; 39(6):659-62. PubMed ID: 8646953
[TBL] [Abstract][Full Text] [Related]
9. Effect of sulindac on sporadic colonic polyps.
Ladenheim J; Garcia G; Titzer D; Herzenberg H; Lavori P; Edson R; Omary MB
Gastroenterology; 1995 Apr; 108(4):1083-7. PubMed ID: 7698575
[TBL] [Abstract][Full Text] [Related]
10. Effect of sulindac treatment for attenuated familial adenomatous polyposis with a new germline APC mutation at codon 161: report of a case.
Esaki M; Matsumoto T; Mizuno M; Kobori Y; Yoshimura R; Yao T; Iida M
Dis Colon Rectum; 2002 Oct; 45(10):1397-402; discussion 1402-6. PubMed ID: 12394442
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF
Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490
[TBL] [Abstract][Full Text] [Related]
12. Sulindac increases the expression of APC mRNA in malignant colonic epithelial cells: an in vitro study.
Schnitzler M; Dwight T; Robinson BG
Gut; 1996 May; 38(5):707-13. PubMed ID: 8707116
[TBL] [Abstract][Full Text] [Related]
13. [Treatment with sulindac of adenomatous polyps in familial polyposis].
Cerdán FJ; Torres-Melero J; Martínez S; Gutiérrez del Olmo A; Balibrea JL
Rev Esp Enferm Dig; 1995 Aug; 87(8):574-6. PubMed ID: 7577106
[TBL] [Abstract][Full Text] [Related]
14. Sulindac treatment for familial polyposis coli.
Gonzaga RA; Lima FR; Carneiro S; Maciel J; Amarante Júnior M
Lancet; 1985 Mar; 1(8431):751. PubMed ID: 2858014
[No Abstract] [Full Text] [Related]
15. Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis.
Giardiello FM; Casero RA; Hamilton SR; Hylind LM; Trimbath JD; Geiman DE; Judge KR; Hubbard W; Offerhaus GJ; Yang VW
Gastroenterology; 2004 Feb; 126(2):425-31. PubMed ID: 14762779
[TBL] [Abstract][Full Text] [Related]
16. [Sulindac in familial adenomatous polyposis coli--preliminary findings of a prospective study].
Müller A; Hürlimann R; Meyenberger C; Staub P; Kobler E; Ammann R
Schweiz Med Wochenschr; 1994 Apr; 124(15):651-4. PubMed ID: 8191270
[TBL] [Abstract][Full Text] [Related]
17. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis.
Chiu CH; McEntee MF; Whelan J
Cancer Res; 1997 Oct; 57(19):4267-73. PubMed ID: 9331087
[TBL] [Abstract][Full Text] [Related]
18. Effects of sulindac on sporadic colorectal adenomatous polyps.
Matsuhashi N; Nakajima A; Fukushima Y; Yazaki Y; Oka T
Gut; 1997 Mar; 40(3):344-9. PubMed ID: 9135523
[TBL] [Abstract][Full Text] [Related]
19. NSAID effect on sporadic colon polyps.
Hixson LJ; Earnest DL; Fennerty MB; Sampliner RE
Am J Gastroenterol; 1993 Oct; 88(10):1652-6. PubMed ID: 8213705
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
